Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annika Gutsche

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Skin Health and Disease|October 2, 2025
Observations on quality of life and disease control in patients with hereditary angioedemaThomas Buttgereit, Annika Gutsche, Markus Magerl
Clinical and Translational Allergy|January 4, 2025
Disease control and quality of life in chronic spontaneous urticaria and recurrent angioedema are strongly linked, but not in all patientsSophia Neisinger, Pascale Salameh, Annika Gutsche, et al.
Allergy|April 1, 2022
Idiopathic mast cell activation syndrome is more often suspected than diagnosed-A prospective real-life studyThomas Buttgereit, Sophie Gu, Leonor Carneiro-Leão, et al.
Allergy|October 4, 2021
Identification of chronic urticaria subtypes using machine learning algorithmsMurat Türk, Ragıp Ertaş, Engin Zeydan, et al.
Allergy|July 13, 2023
Urticaria Control Test real-world performance: A post-hoc analysisPascale Salameh, Annika Gutsche, Felix Aulenbacher, et al.
Allergy|November 3, 2023
Response to "Clinical applicability of the Urticaria control test in patients with chronic urticaria: Further evidence from 622 adult and pediatric patients with different disease subtypes"Annika Gutsche, Pascale Salameh, Felix Aulenbacher, et al.
Frontiers in Immunology|May 27, 2024
The real life experience goes on: update after 4 years on the first cohort treated with lanadelumab at our centerThomas Buttgereit, Carolina Vera Ayala, Seda Aykanat, et al.
Clinical and Translational Allergy|November 13, 2024
Assessing the reliability of the FricTest<sup>®</sup> 4.0 for diagnosing symptomatic dermographismAnnika Gutsche, Martin Metz, Melba Munoz, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 23, 2021
Lanadelumab Efficacy, Safety, and Injection Interval Extension in HAE: A Real-Life StudyThomas Buttgereit, Carolina Vera, Karsten Weller, et al.
Allergy|April 11, 2022
Development of the Cold Urticaria Activity ScoreDalia Melina Ahsan, Sabine Altrichter, Annika Gutsche, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Skin Health and Disease|October 2, 2025
Observations on quality of life and disease control in patients with hereditary angioedemaThomas Buttgereit, Annika Gutsche, Markus Magerl
Clinical and Translational Allergy|January 4, 2025
Disease control and quality of life in chronic spontaneous urticaria and recurrent angioedema are strongly linked, but not in all patientsSophia Neisinger, Pascale Salameh, Annika Gutsche, et al.
Allergy|April 1, 2022
Idiopathic mast cell activation syndrome is more often suspected than diagnosed-A prospective real-life studyThomas Buttgereit, Sophie Gu, Leonor Carneiro-Leão, et al.
Allergy|October 4, 2021
Identification of chronic urticaria subtypes using machine learning algorithmsMurat Türk, Ragıp Ertaş, Engin Zeydan, et al.
Allergy|July 13, 2023
Urticaria Control Test real-world performance: A post-hoc analysisPascale Salameh, Annika Gutsche, Felix Aulenbacher, et al.
Allergy|November 3, 2023
Response to "Clinical applicability of the Urticaria control test in patients with chronic urticaria: Further evidence from 622 adult and pediatric patients with different disease subtypes"Annika Gutsche, Pascale Salameh, Felix Aulenbacher, et al.
Frontiers in Immunology|May 27, 2024
The real life experience goes on: update after 4 years on the first cohort treated with lanadelumab at our centerThomas Buttgereit, Carolina Vera Ayala, Seda Aykanat, et al.
Clinical and Translational Allergy|November 13, 2024
Assessing the reliability of the FricTest<sup>®</sup> 4.0 for diagnosing symptomatic dermographismAnnika Gutsche, Martin Metz, Melba Munoz, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 23, 2021
Lanadelumab Efficacy, Safety, and Injection Interval Extension in HAE: A Real-Life StudyThomas Buttgereit, Carolina Vera, Karsten Weller, et al.
Allergy|April 11, 2022
Development of the Cold Urticaria Activity ScoreDalia Melina Ahsan, Sabine Altrichter, Annika Gutsche, et al.
Pageof 2